mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.01 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |